Though fasting concentrations and subsequent HOMA calculations offer only gross approximations of insulin sensitivity, these findings indicate that neither hyperglycemia nor hyperinsulinemia are likely to be key factors influencing primary outcomes. The gene discussed is INS; the disease is Hyperinsulinemia.